Jelle Demeestere1, Sören Christensen2, Michael Mlynash2, Christian Federau3, Gregory W Albers2, Robin Lemmens4, Maarten G Lansberg2. 1. KU Leuven - University of Leuven, Department of Neurosciences, Experimental Neurology, Leuven, Belgium; VIB, Center for Brain & Disease Research, Laboratory of Neurobiology, Leuven, Belgium; University Hospitals Leuven, Department of Neurology, Herestraat 49, Leuven B-3000, Belgium. Electronic address: jelle.demeestere@uzleuven.be. 2. Stanford Stroke Center, Stanford, United States. 3. Institute for biomedical Engineering, University and ETH Zürich, Switzerland. 4. KU Leuven - University of Leuven, Department of Neurosciences, Experimental Neurology, Leuven, Belgium; VIB, Center for Brain & Disease Research, Laboratory of Neurobiology, Leuven, Belgium; University Hospitals Leuven, Department of Neurology, Herestraat 49, Leuven B-3000, Belgium.
Abstract
BACKGROUND AND PURPOSE: It is unclear if sex differences explain some of the variability in the outcomes of stroke patients who undergo endovascular treatment (EVT). In this study we assess the effect of sex on radiological and functional outcomes in EVT-treated acute stroke patients and determine if differences in baseline perfusion status between men and women might account for differences in outcomes. METHODS: We included patients from the CRISP (Computed tomographic perfusion to Predict Response to Recanalization in ischemic stroke) study, a prospective cohort study of acute stroke patients who underwent EVT up to 18 hours after last seen well. We designed ordinal regression and univariable and multivariable regression models to examine the association between sex and infarct growth, final infarct volume and 90-day mRS score. RESULTS: We included 198 patients. At baseline, women had smaller perfusion lesions, more often had a target mismatch perfusion profile, and had better collateral perfusion. Women experienced less ischemic core growth (median 15 mL vs. 29 mL, p < 0.01) and had smaller final infarct volumes (median 26 mL vs. 50 mL, p < 0.01). Female sex was associated with a favorable shift on the modified Rankin Scale (adjusted cOR 1.79 [1.04 - 3.08; p = 0.04]) and lower odds of severe disability or death (adjusted OR 0.29 [0.10 - 0.81]; p = 0.02). CONCLUSIONS: The results suggest that women have better collaterals and, therefore, more often exhibit a favorable imaging profile on baseline imaging, experience less lesion growth, and have better clinical outcomes following endovascular therapy.
BACKGROUND AND PURPOSE: It is unclear if sex differences explain some of the variability in the outcomes of stroke patients who undergo endovascular treatment (EVT). In this study we assess the effect of sex on radiological and functional outcomes in EVT-treated acute stroke patients and determine if differences in baseline perfusion status between men and women might account for differences in outcomes. METHODS: We included patients from the CRISP (Computed tomographic perfusion to Predict Response to Recanalization in ischemic stroke) study, a prospective cohort study of acute stroke patients who underwent EVT up to 18 hours after last seen well. We designed ordinal regression and univariable and multivariable regression models to examine the association between sex and infarct growth, final infarct volume and 90-day mRS score. RESULTS: We included 198 patients. At baseline, women had smaller perfusion lesions, more often had a target mismatch perfusion profile, and had better collateral perfusion. Women experienced less ischemic core growth (median 15 mL vs. 29 mL, p < 0.01) and had smaller final infarct volumes (median 26 mL vs. 50 mL, p < 0.01). Female sex was associated with a favorable shift on the modified Rankin Scale (adjusted cOR 1.79 [1.04 - 3.08; p = 0.04]) and lower odds of severe disability or death (adjusted OR 0.29 [0.10 - 0.81]; p = 0.02). CONCLUSIONS: The results suggest that women have better collaterals and, therefore, more often exhibit a favorable imaging profile on baseline imaging, experience less lesion growth, and have better clinical outcomes following endovascular therapy.
Authors: Maarten G Lansberg; Soren Christensen; Stephanie Kemp; Michael Mlynash; Nishant Mishra; Christian Federau; Jenny P Tsai; Sun Kim; Raul G Nogueria; Tudor Jovin; Thomas G Devlin; Naveed Akhtar; Dileep R Yavagal; Diogo Haussen; Seena Dehkharghani; Roland Bammer; Matus Straka; Greg Zaharchuk; Michael P Marks; Gregory W Albers Journal: Ann Neurol Date: 2017-06-09 Impact factor: 10.422
Authors: Mayank Goyal; Bijoy K Menon; Wim H van Zwam; Diederik W J Dippel; Peter J Mitchell; Andrew M Demchuk; Antoni Dávalos; Charles B L M Majoie; Aad van der Lugt; Maria A de Miquel; Geoffrey A Donnan; Yvo B W E M Roos; Alain Bonafe; Reza Jahan; Hans-Christoph Diener; Lucie A van den Berg; Elad I Levy; Olvert A Berkhemer; Vitor M Pereira; Jeremy Rempel; Mònica Millán; Stephen M Davis; Daniel Roy; John Thornton; Luis San Román; Marc Ribó; Debbie Beumer; Bruce Stouch; Scott Brown; Bruce C V Campbell; Robert J van Oostenbrugge; Jeffrey L Saver; Michael D Hill; Tudor G Jovin Journal: Lancet Date: 2016-02-18 Impact factor: 79.321
Authors: Sunil A Sheth; Songmi Lee; Steven J Warach; Jan Gralla; Reza Jahan; Mayank Goyal; Raul G Nogueira; Osama O Zaidat; Vitor M Pereira; Adnan Siddiqui; Helmi Lutsep; David S Liebeskind; Louise D McCullough; Jeffrey L Saver Journal: Stroke Date: 2019-08-15 Impact factor: 7.914
Authors: David S Liebeskind; Thomas A Tomsick; Lydia D Foster; Sharon D Yeatts; Janice Carrozzella; Andrew M Demchuk; Tudor G Jovin; Pooja Khatri; Ruediger von Kummer; Rebecca M Sugg; Osama O Zaidat; Syed I Hussain; Mayank Goyal; Bijoy K Menon; Firas Al Ali; Bernard Yan; Yuko Y Palesch; Joseph P Broderick Journal: Stroke Date: 2014-01-28 Impact factor: 7.914
Authors: Anna M M Boers; Ivo G H Jansen; Henk A Marquering; Charles B L M Majoie; Ludo F M Beenen; Thomas G Devlin; Luis San Roman; Ji Hoe Heo; Marc Ribó; Scott Brown; Mohammed A Almekhlafi; David S Liebeskind; Jeanne Teitelbaum; Hester F Lingsma; Wim H van Zwam; Patricia Cuadras; Richard du Mesnil de Rochemont; Marine Beaumont; Martin M Brown; Albert J Yoo; Robert J van Oostenbrugge; Bijoy K Menon; Geoffrey A Donnan; Jean Louis Mas; Yvo B W E M Roos; Catherine Oppenheim; Aad van der Lugt; Richard J Dowling; Michael D Hill; Antoni Davalos; Thierry Moulin; Nelly Agrinier; Andrew M Demchuk; Demetrius K Lopes; Lucia Aja Rodríguez; Diederik W J Dippel; Bruce C V Campbell; Peter J Mitchell; Fahad S Al-Ajlan; Tudor G Jovin; Jeremy Madigan; Gregory W Albers; Sebastien Soize; Francis Guillemin; Vivek K Reddy; Serge Bracard; Jordi Blasco; Keith W Muir; Raul G Nogueira; Phil M White; Mayank Goyal; Stephen M Davis Journal: J Neurointerv Surg Date: 2018-04-07 Impact factor: 5.836